TFOS DEWS III: From Evidence to Everyday Practice

Sep 23th 2025

Featured News

Dry Eye Disease (DED) remains one of the most commonly encountered and evolving challenges in modern eye care. The TFOS (The Tear Film and Ocular Surface Society) recently published the DEWS III Report, a comprehensive, evidence-based report that updates the global consensus on the definition, diagnosis, and management of dry eye disease (DED).

We have brought together four key authors from the TFOS DEWS III report—Professors Lyndon Jones, Jennifer Craig, Fiona Stapleton, and James Wolffsohn—who, in four brief, on-demand videos, will provide you with the latest insights from this important publication.

This new CPD course offers exclusive, on-demand access into the report’s findings. Whether you’re an Ophthalmologist, Optometrist, IP Optometrist, GP, Pharmacist, or Allergy Specialist, these videos will give you insights into the latest diagnostic tools, patient management strategies, and practical updates from DEWS III, ready to implement in your daily practice.

Click here to register or view details about our upcoming TFOS DEWS III webinar

Click here to view course

Watch the first 5 minutes below:

Click here to view course

Course Overview

This CPD course features five pre-recorded sessions led by some of the key authors of the DEWS III report:

1. Diagnosis Made Clear with Prof James Wolffsohn

James Wolffsohn, breaks down the refined definition of DED, introduces a streamlined diagnostic pathway (including OSDI-6, non-invasive TBUT, osmolarity, and ocular surface staining), and explains a new driver-based subclassification system to make diagnosis faster, more consistent, and easier to communicate to patients.

2. A Digest of Change with Prof Fiona Stapleton

From hormonal influences to iatrogenic causes, Fiona Stapleton’s session on DEWS III walks you through what’s new in epidemiology, tear film science, pain perception, and risk factors. Her insights offer important reminders about medication and surgery-related dry eye, and why future-fit trials must align outcomes with mechanisms.

3. Treatment You Can Action with Prof Lyndon Jones

Lyndon Jones, delivers a clear, evidence-based treatment strategy organised into three intuitive algorithms—covering tear film, lids, and ocular surface/adnexa. With ten treatment categories (from MGD to biologics, nutrition to lifestyle), this is a must-watch for clinicians wanting clarity in care pathways.

4. Real-World Pearls with Prof Jennifer Craig

Jennifer Craig closes the loop by showing you how to embed the DEWS III updates into your existing protocols. With practical checklists, workflow suggestions, and clinic-ready pearls, she helps you take insights off the page and into practice—improving outcomes for both your team and your patients.

Click here to view course

Meet The Experts

James S. Wolffsohn, BSc, PhD, PGDip, PGCert, MBA

Deputy Vice-Chancellor and Professor at Aston University, Birmingham. He has published over 300 peer-reviewed papers, chaired the TFOS DEWS III Diagnostic Methodology Report, and co-authored multiple international consensus statements on contact lens discomfort, presbyopia, and myopia management.

Fiona J. Stapleton, BSc (Hons), MSc, PhD, FCOptom, FTSE, FAAO (Dip)

A Professor of Optometry at UNSW Sydney and chair of the TFOS DEWS III Digest Report. A recognised leader in corneal and ocular surface research, she has published extensively on microbial keratitis, contact lens-related disease, and dry eye epidemiology.

Lyndon W. J. Jones, BOptom, PhD, DSc (Hon), FCOptom, FAAO, FCAHS, FIACLE, FBCLA

University Professor at the University of Waterloo, Canada and Director of the Centre for Ocular Research & Education (CORE). As Chair of the TFOS DEWS III Management and Therapy Report, he led the systematic evaluation of current and emerging therapies, producing new evidence-based treatment algorithms.

Jennifer P. Craig, PhD, FCOptom, FAAO, FBCLA, FACLS

Professor at the University of Auckland, New Zealand, and a global authority on dry eye disease, meibomian gland dysfunction, and ocular surface imaging. She has played a central role in TFOS initiatives for over a decade, co-chairing the Definition & Classification Report in DEWS II, and co-authoring the TFOS DEWS III Editorial.

Click here to view course

Need more TFOS DEWS III insights?

Register for our upcoming webinar on 9th of September for a very special panel discussion featuring 3 authors from the TFOS DEWS III Report committee to learn how the newest evidence and recommendations can transform your patient management, with practical insights directly from the clinic.

Download